Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 February 2019 | Story Zama Feni | Photo Charl Devenish
Disease Control and Prevention InStory
From left, seated: Dr Mathew Esona, CDC delegate; Dr Michael Bowen, CDC delegate; Dr Martin Nyaga, lead Researcher at the UFS-NGS Unit; standing: Mojalefa Buti, Office of the Vice-Dean, UFS Faculty of Health Sciences; Dr Glen Tylor, Senior Director, Directorate Research Development; Cornelius Hagenmeier, Director, Office for International Affairs; and Dr Saheed Sabiu, Postdoctoral Research Fellow in the Faculty of Natural and Agricultural Sciences.

In pursuit of efforts to advance research on viruses and disease control, the United States-based Centre for Disease Control and Prevention (CDC) has made a commitment to enhance the University of the Free State (UFS) Next Generation Sequencing (NGS) Unit’s data collection systems and further empower its staff and students.

UFS and US guests explore areas of mutual; cooperation

During a visit to the university in early December last year CDC delegation, Dr Michael Bowen and Dr Mathew Esona, a meeting was held with the lead Researcher at the UFS-NGS Unit, Dr Martin Nyaga; Senior Director of the UFS Directorate Research Development, Dr Glen Tylor; Director of UFS Office for International Affairs, Cornelius Hagenmeier; and Dr Saheed Sabiu Postdoctoral Research Fellow in the Faculty of Natural and Agriculture Sciences. It was in this meeting that areas of mutual collaboration and engagement between the two institutions which include technology transfer, funding and wet and dry laboratory quality control and capacity development were identified.

The UFS-NGS Unit, established in 2016, enjoys longstanding networking and collaborative ventures with renowned researchers in Africa, the USA, and Europe – which in return, have contributed immensely to the research activities of the university as a whole.

Dr Nyaga said in an effort to advance genomics research in the NGS Unit, the visitors have committed themselves to initiate and further enhance capacity development for the unit’s staff and students.

US guests impressed with advanced equipment at UFS

The CDC delegation were intrigued that the UFS also operates a Miseq Illumina platform like the one used at their enteric-viruses laboratory. It could thus be in line to assist in developing exclusive pipelines for the analysis of NGS data generated by the UFS-NGS Unit.

This is a personal sequencing system, which is a powerful state-of-the-art next-generation sequencer. It uses sequencing-by-synthesis technology capable of sequencing up to 15GB of high-quality filtered bases per run, with up to 600 base-pair read lengths. This allows the assembly of small genomes or the detection of target variants with unmatched accuracy, especially within homo-polymer regions.

UFS and CDC engagements still on

Further engagements about the identified areas of collaboration are ongoing between Hagenmeier, Dr Bowen, and Dr Nyaga, who are currently working on appropriate mechanisms to enact the envisaged collaboration between the two institutions.

The NGS Unit received research awards from the World Health Organisation, South African Medical Research Council, Poliomyelitis Research Foundation, and the National Research Foundation for different aspects of genomics research, and more recently from the Bill and Melinda Gates Foundation for the Enteric Viruses Genome Initiative, involving four African countries (South Africa, Ghana, Malawi, and Cameroon).

News Archive

UFS launches expansions to Biotechnology Building
2015-11-04

     

Biotechnology Building
Photo: Leonie Bolleurs

To support the strategic focus of the University of the Free State (UFS) on teaching and learning in the field of Biotechnology, the Department of Microbial, Biochemical, and Food Biotechnology introduced upgrades and additions to the value of R23 million to the existing Biotechnology Building on its Bloemfontein Campus. The funding was provided by the Department of Higher Education and Training.

The new section, together with renovations to the existing part of the Biotechnology Building, was opened on Thursday 29 October 2015.

The Department, consisting of three disciplines - Microbiology, Biochemistry, and Food Biotechnology - is extremely diverse. Two of the three disciplines – Microbiology and Biochemistry – are housed in the Biotechnology Building.

Additions and renovations to the Biotechnology Building include:
-    Four new research laboratories
-    Nine revamped research laboratories

      

At the launch of the Biotechnology Building were,
from the left: Nico Janse van Rensburg,
Senior Director: University Estates;
Maureen Khati, University Estates,
Prof Nicky Morgan, Vice Rector: Operations
and Ria Deysel, Director: Facilities Management.
Photo: Leonie Bolleurs

The work to the building will have dramatic effects on the quality, as well as the quantity, of postgraduate students. Given the national priority to deliver students, this is very important, particularly at the doctorate level.

Prof Koos Albertyn from the Department said these were the first renovations and expansions done to the building since 1 January 1990. “We welcome the extra space. Forty-six more postgraduate students can now be accommodated in the department,” he said.

Construction took place on the south-western corner of the existing building. Further developments to the building include:
-    Six new offices
-    A lecture hall for 70 students
-    Laboratories that can accommodate 56 postgraduate students

Prof Martie Smit, Academic Head of the Department, said: “This new and refurbished facility enables us to give our best. As academics, we are committed to doing our part in delivering high-quality education at both undergraduate and postgraduate levels to students envisaging a future in biotechnology.”

The James Charles du Preez Seminar Room was also opened at the event. The seminar room is dedicated to Prof Du Preez – who was Head of the Department from October 2002 until the end of 2014. He played a major role in raising funds for upgrading the Biotechnology Building, including the addition of a new wing.



We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept